Deltagen Financial Statements From 2010 to 2024
| DGEN Stock | USD 0.0001 0.00 0.00% |
Check Deltagen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Deltagen's main balance sheet or income statement drivers, such as , as well as many indicators such as . Deltagen financial statements analysis is a perfect complement when working with Deltagen Valuation or Volatility modules.
Deltagen |
Deltagen Company Operating Margin Analysis
Deltagen's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Deltagen Operating Margin | (0.06) % |
Most of Deltagen's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Deltagen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Deltagen has an Operating Margin of -0.0597%. This is 99.83% lower than that of the Biotechnology sector and 98.73% lower than that of the Health Care industry. The operating margin for all United States stocks is 98.92% lower than that of the firm.
Deltagen Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Deltagen's current stock value. Our valuation model uses many indicators to compare Deltagen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Deltagen competition to find correlations between indicators driving Deltagen's intrinsic value. More Info.Deltagen is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Deltagen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Deltagen's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Deltagen Financial Statements
Deltagen investors utilize fundamental indicators, such as revenue or net income, to predict how Deltagen Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Deltagen, Inc. provides drug discovery tools and services to the biopharmaceutical industry and to the academic research community in the United States. The company was founded in 1997 and is headquartered in San Mateo, California. Deltagen operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange.
Pair Trading with Deltagen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Deltagen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deltagen will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Deltagen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Deltagen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Deltagen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Deltagen to buy it.
The correlation of Deltagen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Deltagen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Deltagen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Deltagen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Deltagen Pink Sheet
Deltagen financial ratios help investors to determine whether Deltagen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Deltagen with respect to the benefits of owning Deltagen security.